TITLE

Evidence in practice -- number 8 What is the prognosis of optic neuritis?

AUTHOR(S)
Sanders, Sharon; Del Mar, Chris; Purdy, Sarah; Spinks, Annelise; Tait, Lisa; McAvoy, Brian
PUB. DATE
December 2005
SOURCE
British Journal of General Practice;Dec2005, Vol. 55 Issue 521, p972
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a case on the chance of developing multiple sclerosis following a first episode of optic neuritis. The risk of developing multiple sclerosis ranged from 13 to 58%. Abnormal brain magnetic resonance imaging was a strong predictor of multiple sclerosis in a study. It provides information on other studies related to the disease.
ACCESSION #
19888468

 

Related Articles

  • The prognosis of idiopathic optic neuritis. Ghezzi, A.; Martinelli, V.; Rodegher, M.; Zaffaroni, M.; Comi, G. // Neurological Sciences;Dec2000 Supplement 2, Vol. 21, pS865 

    We evaluated the risk of developing clinically definite multiple sclerosis (CDMS) after acute isolated optic neuritis in 102 patients in a follow-up study (duration 6.5±2.0 years). The probability of CDMS was 13% after 2 years, 30% after 4 years, 38% after 6 years, and 49% after 8 and 10...

  • Brain MRI useful for predicting risk of MS in optic neuritis. Groves, Nancy // Ophthalmology Times;3/15/2008, Vol. 33 Issue 9, p20 

    The article focuses on the use of brain magnetic resonance imaging (MRI) for predicting the risks of multiple sclerosis development in patients with optic neuritis. It discusses the Optic Neuritis Treatment Trial and the Longitudinal Optic Neuritis Study, and mentions their findings regarding...

  • Short term outcomes of the use of high dose intravenous methylprednisolone for acute optic neuritis in a central Anatolian population. Özdamar, Yasemin; Acaroğlu, Gölge; İlhan, Bayazıt; Özkan, Seyhan S.; Teberık, Kuddusi // Turkish Journal of Medical Sciences;2009, Vol. 39 Issue 6, p901 

    Aim: To describe the clinical characteristics and outcome of optic neuritis (ON) cases treated with high dose intravenous methylprednisolone (IVMP) in a tertiary referral clinic in Ankara, Turkey. Methods: Consecutive patients in the past 5 years with acute isolated ON, who were treated with...

  • MRI.  // Multiple Sclerosis (13524585);Sep99 Supplement, Vol. 5, pS51 

    The article presents abstracts of medical research related to multiple sclerosis. They include "Paroxysmal Dystonia (PD) in Multiple Sclerosis (MS): A Proposal for Anatomical Correlation Criteria," "Calculation of Optic Nerve Area Following Unilateral Optic Neuritis Using a Short Echo Fast Flair...

  • Clinical and Radiological Spectrum of Multiple Sclerosis (MS). Mishra, S.; Mehndiratta, M. M.; Pandey, S.; Garg, R. // Annals of Indian Academy of Neurology;Nov2008 Supplement, Vol. 11, pS138 

    Aim and Objectives: Multiple Sclerosis may have varied presentation. The Multiple Sclerosis can present Relapsing Remitting Multiple Sclerosis (RRMS), Primary Progressive Multiple Sclerosis (PPMS), Secondary Progressive Multiple Sclerosis (SPMS), Progressive Relapsing Multiple Sclerosis (PRMS)...

  • Intrathecal synthesis of virus-specific oligoclonal IgG, and of free kappa and free lambda oligoclonal bands in acute monosymptomatic optic neuritis. Comparison with brain MRI. Frederiksen, J.L.; Sindic, C.J.M. // Multiple Sclerosis (13524585);Feb98, Vol. 4 Issue 1, p22 

    Twenty-seven patients with acute monosymptomatic optic neuritis were randomly selected from a population-based cohort of patients extensively screened for known etiologies of ON. Paired serum and CSF obtained median 20 days from onset were examined for oligoclonal IgG, free kappa and free lambda...

  • Clinically isolated syndromes with no further disease activity suggestive of multiple sclerosis at the age of population life expectancy. Novakova, L; Skoog, B; Runmarker, B; Ekholm, S; Winblad, S; Lisovskaja, V; Andersen, O // Multiple Sclerosis Journal;Apr2014, Vol. 20 Issue 4, p496 

    The proportion of patients with clinically isolated syndrome (CIS) reported to convert to clinically definite multiple sclerosis varied between 30 and 75%. We studied the lifetime probability of remaining in the “CIS only” condition. The study was based on the longitudinally followed...

  • Defining high, medium and low impact prognostic factors for developing multiple sclerosis. O'Sullivan, Eoin // Current Medical Literature: Ophthalmology;2015, Vol. 25 Issue 3, p95 

    The article discusses a 2015 study by M. Tintore et al and published in the journal "Brain" that deals with factors that can predict the possibility of a patient who previously suffered a clinically isolated syndrome to develop multiple sclerosis. Topics include patients presenting with optic...

  • Baseline MRI characteristics of patients at high risk for multiple sclerosis: results from the CHAMPS trial. CHAMPS Study Group // Multiple Sclerosis (13524585);Aug2002, Vol. 8 Issue 4, p330 

    The baseline MRI studies from the Controlled High-Risk Subjects Avonex Multiple Sclerosis Prevention Study (CHAMPS) trial, a randomized, longitudinal, double-blind trial of 383 patients with a first acute clinical demyelinating event and evidence of prior subclinical demyelination on magnetic...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics